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Fatigue, Sleep, and Mood in
Patients With Axial Spondyloarthritis:
Secondary Analysis of a
Randomized Controlled Trial
Silje Halvorsen Sveaas, Hanne Dagfinrud, Inger Jorid Berg, Sella Arrestad Provan,
Melissa Woll Johansen, Elisabeth Pedersen, Annelie Bilberg
Objective. Although exercise is recommended in the treatment of axial spondyloarthritis
(axSpa), the focus has been on flexibility, and the effect of high-intensity exercises is
unknown. The purpose of this study was to investigate the effect of high-intensity exercises
on fatigue, sleep, and mood in patients with axSpA.
Methods. In this secondary analysis of a randomized controlled trial, participants were
recruited from outpatient clinics at 4 hospitals in Scandinavia. A total of 100 patients with
axSpA were randomized to either an exercise group (n = 50) or a control group (n = 50).
High-intensity exercise was provided 3 times per week for 3 months and supervised
by a physical therapist. The controls received no intervention. Measurements were self-
reported at baseline, 3 months, and 12 months: fatigue, using the Fatigue Severity Scale
(range = 0–7, 7 = worst, ≥5 = severe); vitality, using the RAND 36-item short-form health
survey (SF-36, range = 0–100, 100 = best); sleep, using the Pittsburgh Sleep Quality
Index (range = 0–21, 21 = worst, >5 = poor quality); mood, using the General Health
Questionnaire 12 (range = 0–36, 36 = worst); and general health, using the EUROQoL
(range = 0–100, 100 = best).
Results. A total of 38 participants (76%) in the exercise group followed ≥80% of the
exercise protocol. At 3 months, there was a significant beneficial effect on fatigue (mean
group differences = −0.4, 95% CI = −0.7 to −0.1), vitality (5.0, 95% CI = 1.1 to 10.5),
mood (−2, 95% CI = −3.7 to −0.04), and general health (9.0, 95% CI = 3.3 to 14.7) but
no effect on sleep (−1.1, 95% CI = −2.1 to 0.2). Compared with the control group, the
exercise group had a reduced rate of severe fatigue and poor sleep. No differences were
seen between the groups at 12 months.
Conclusions. A 3-month exercise program had a beneficial effect on fatigue, sleep,
mood, and general health in patients with axSpA at the end of the intervention; however,
no long-term effects were seen.
Impact. High-intensity cardiorespiratory and strength exercises should be considered as
important in exercise programs for patients with axSpA.
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Axial spondyloarthritis (axSpA) is a chronicinflammatory rheumatic disease primarily affectingthe axial skeleton with a prevalence of 0.3% to
1.4%.1 AxSpA covers both patients with radiographic,
structural damage of the axial skeleton (ankylosing
spondylitis) and patients without structural damage
(non-radiographic axSpA). The disease usually debuts in
early adulthood, and men and women are equally affected
by axSpA,1 but more men develop ankylosing spondylitis.
The typical clinical features are back pain and stiffness,
but patients report that besides pain, fatigue and sleep are
their most important health aspects.2,3 Disease-related
fatigue is described as a feeling of abnormal lack of
energy that is not relieved by rest and unlike the feeling
of tiredness in healthy adults.4 Fatigue is explained by an
interplay between different factors such as inflammation,
medication, pain, sleep, and deconditioning5 and is
reported to correlate with mood disorders such as
depression and anxiety.6 Hence, effective treatment
strategies to reduce fatigue in patients with axSpA are
needed.
Physical therapy with exercises is recommended as a
cornerstone in the management of axSpA together with
pharmacological treatment.7 Pharmacological treatment
options (biologic agents) have been shown to be effective
in reducing disease activity8 and overall sleep scores,9 but
whether medication has a beneficial effect on fatigue and
mood disorders is more uncertain.10 As in the general
population, few patients with axSpA meet the general
physical activity recommendations,11,12 and few practice
vigorous13,14 and aerobic physical activity.12 Therefore, it
may be hypothesized that an improvement in physical
fitness may reduce the burden of fatigue in patients with
axSpA.
Exercise is shown to have a positive effect on fatigue,
vitality, mood,15,16 and sleep quality17 in the general
population. The evidence for a similar effect in patients
with axSpA is limited as fatigue, sleep, and mood are
seldom used as outcome measures in exercise trials. A
beneficial effect of exercise on fatigue has been reported
for patients with different inflammatory rheumatic
disease.18,19 However, previous research tended to focus on
low-intensity flexibility exercises for patients with axSpA,
and exercise intensity is crucial for the physiological
effects.16 Hence, the potential effect of exercise on fatigue
and mood in this patient group is not completely revealed.
Our research group recently completed a clinical trial that
showed that high-intensity exercises reduced disease
activity measured with the Ankylosing Spondylitis Disease
Activity Score and the Bath Ankylosing Spondylitis
Disease Activity Index, indicating that high-intensity
exercises are safe for this patient group.20 Therefore, the
aim of this secondary analysis was to investigate the effect
of high-intensity cardiorespiratory and strength exercises
on fatigue, mood, sleep quality, and perceived general
health in patients with axSpA.
Methods
Design
This study was a secondary analysis of an
assessor-blinded, 2-armed, multicenter, randomized
controlled trial comparing the effects of 3 months of
high-intensity exercises with no intervention (the Exercise
for Spondyloarthritis [ESpA] study). Our study group have
previously published a pilot study of this trial.21 The trial
was conducted at rheumatology departments in Norway
(Diakonhjemmet Hospital [DH], Martina Hansen Hospital
[MHH] and the University Hospital of North Norway
[UNN]) and in Sweden (Sahlgrenska University Hospital
[SUH]). The study was approved by the Regional
Committee for Medical and Health Research Ethics (REK
South East 2015/86) in Norway and the Regional Ethical
Review Board Gothenburg in Sweden (032–16). All
procedures followed the Declaration of Helsinki, and all
participants gave written and oral informed consent
before entering. The study protocol is registered at
ClinicalTrials.gov (NCT02356874).
Participants
Patients were recruited from outpatient rheumatology
departments at the 4 study centers as well as through
various social media channels such as Facebook and
websites for patients. The inclusion criteria were axSpA
diagnosis (Assessment of SpondyloArthritis international
Society criteria),22 age 18 to 70 years, no change in tumor
necrosis factor inhibitor use during the previous 3 months,
moderate to high disease activity (Bath Ankylosing
Spondylitis Disease Activity Index ≥3.5)23 at prescreening,
and not having performed regular cardiorespiratory or
strength exercises >1 hour per week during the last 6
months. Exclusion criteria were established or symptoms
of coronary heart disease (for details see Supplementary
eFile 1), other comorbidity involving reduced exercise
capacity (any contraindications/not able to exercise at a
high intensity), inability to participate in weekly
supervised exercise sessions, and pregnancy. Prescreening
was administered by telephone.
Exercise Intervention
The exercise program followed the American College of
Sports Medicine exercise recommendations for
cardiorespiratory and strength exercises and is described
in detail in Supplementary eFile 2. Patients in the exercise
group were encouraged to exercise 3 times a week for
3 months. Physical therapists specialized in rheumatology
and trained in the exercise protocol supervised the
exercises sessions twice a week at each study center. The
supervised exercise sessions were organized as group
sessions (7–12 participants) at the hospital at 2 of the
study centers (UNN and SUH), whereas the physical
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therapist supervised the participants individually at a
fitness center at the 2 other study centers (DH and MHH).
These supervised sessions consisted of 40 minutes of
cardiorespiratory exercise and 20 minutes of strength
exercises. The cardiorespiratory exercise was performed
on a treadmill or a cycle ergometer at high intensity (10
minutes of warm-up, thereafter 4 minutes of forceful
walking/running or bicycling at 90%–95% of maximal
heart rate [HR] followed by 3 minutes of active resting at
70% of maximal HR repeated 4 times).24 Maximal HR was
determined at baseline and was controlled by a Polar
pulse-watch. The strength exercises were individually
adapted to each participant according to the available
equipment at each study center. The strength exercises
focused on major muscle groups (squats, leg press,
deadlifts, rows to chest, bench press, shoulder press,
pulldowns, and sit-ups) and included 8 to 10 repetitions
maximum in 2 to 3 sets. In addition to the supervised
sessions, patients in the exercise group were encouraged
to perform a cardiorespiratory exercise session once a
week on their own for at least 40 minutes on intensity
level above 70% of maximal HR (controlled by
pulse-watch).
As a general rule, some pain (≤5 on a scale from 0–10)
was tolerated during the exercises. However, if the pain
got worse the day after, the exercises were adapted.
Adaptations for pain were conducted on a regular basis,
as it would have been done in a regular physical therapy
practice.
Control Group
Patients in the control group received no intervention and
were asked to continue with their usual physical activity
habits. All included patients received standard outpatient
care from their respective hospitals, but before inclusion
in the study it was specified that no change in medication
before the 3-month assessment was desirable.
Registration of Adherence and Safety
Exercise adherence was recorded by the physical therapist
as attendance at the supervised sessions and as
accomplishment of home sessions. The physical therapist
checked the pulse watch to register fulfilment of home
session every week. Exercise adherence was also
self-reported as the participants in the exercise group
recorded all sessions in a diary. The highest number of
completed sessions reported by the physical therapist or
self-reported in the diary was registered as total number
of completed sessions. Patients in the control group did
not record exercise session but were asked about exercise
habits during the intervention period retrospectively in a
questionnaire at the 3-month assessment.
Any adverse events that occurred during the supervised
sessions or were reported from the participants from the
home sessions were registered by the physical therapist
who was in charge of the exercise program at each study
center.
Outcome Measures
All outcomes were secondary outcomes in the parent
study.20 The primary outcome measure of the ESpA study
was disease activity measured with the Bath Ankylosing
Spondylitis Disease Activity Index23 and the Ankylosing
Spondylitis Disease Activity Score.25 All outcomes were
assessed by patient-reported questionnaire at baseline and
immediately after the 3-month intervention. An assessor
blinded for the participant’s group allocation administered
the data collection and was available for the participants if
they needed help with the questionnaires at the baseline-
and 3-month follow-up assessment. After 12 months, a
questionnaire was sent by postal mail to all participants
together with a prepaid envelope.
Fatigue was assessed with the Fatigue Severity Scale
(FSS).26,27 The FSS consists of 9 statements, each of which
is scored from 1 to 7, where 1 indicates strongly disagree
and 7 strongly agree. The mean of the 9 items yields the
FSS score (0–7, 7 = worst). A cut-off value of ≥5 for severe
fatigue was used.27 FSS is widely used and reported to
have good concurrent validity with visual analog scale
measures of fatigue (0.5–0.8). The FSS is also reported to
have acceptable test-retest reliability (0.84)26 and has the
ability to detect changes over time.28
Vitality was assessed with the vitality domain in the RAND
36-item Short form Health Survey (SF-36).29 The vitality
domain in SF-36 consists of 9 questions regarding vitality
during the last 4 weeks, each scored from 1 (all of the
time) to 6 (not at all), and the mean of the 9 items yields a
sum score from 0 to 100 (100 = best). The SF-36 as version
1 has been tested in rheumatoid arthritis patients, and it
has shown good evidence for internal consistency and
discriminant validity.30
Sleep quality was measured with the Pittsburgh Sleep
Quality index (PSQI).31 The PSQI assesses sleep quality
and disturbance over a 1-month time interval. It consists
of 19 items that are grouped into 7 component scores,
each weighted equally on a 0 to 3 scale, and the 7
components are summed to a global PSQI score (0–21,
21 = worst sleep quality). A cut-off score of >5 was used
to categorize patients with reduced sleep quality.31 PSQI is
widely used, reported to be valid as it discriminates
patients with sleeping problems from controls, and it
correlates to objective measures of sleeping quality
measured by polysomnography.31,32 PSQI is also reported
to have acceptable test-retest reliability.31–33
Mood was measured with the questions from the General
Health Questionnaire 12 (GHQ-12).34 The GHQ-12 is a
widely used and validated instrument that comprises 12
items reflecting several aspects of mood/depression.34
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Each item was answered on a 4-point scale with the
alternatives “not at all,” “no more than usual,” “rather
more than usual,” and “much more than usual.” GHQ-12
gives a sum from 0 to 36 (36 = worst).
Perceived general health was assessed using the EuroQol
applying a 0 to 100 visual analog scale where 0 = worst
health and 100 = best health.35 Finally, background
variables and information on disease-related variables
were collected at baseline.
Sample Size
The estimation of sample size was based on the primary
outcome in the ESpA study,20 disease activity, and based
on this we aimed at recruit 100 patients. Power
calculations were not done for the outcome measures
reported in this study.
Randomization and Blinding
The randomization sequence was computer generated and
stratified according to the study clusters, and a block
randomization with a block size of 4 was used to ensure
an adequate number of patients in the exercise group
during the inclusion period. A secretary not involved in
other aspects of the data collection prepared concealed
envelopes that gave group allocation. The allocation was
administered after baseline testing by the physical
therapist who supervised the exercise sessions to keep the
outcome assessor blinded for group allocation. Blinding of
the participants and the physical therapists supervising
the exercise sessions was not possible.
Statistical Analyses
Data are shown as mean with SD, median with minimum
and maximum values, or frequency with percentages. The
statistical analyses were performed on the
intention-to-treat population. Missing data were replaced
by the last value carried forward approach. For
continuous variables, analyses of covariance (ANCOVA) on
the post-intervention values was used to assess the group
differences with P values, mean difference, and 95% CI at
3- and 12-month follow-up. Baseline values and study
center were included as covariates in the ANCOVA. We
assessed the normality assumptions of the ANCOVA
models by pp-plots of the residuals. To estimate effect
sizes for continuous variables, the standardized mean
difference with 95% CI was calculated using Review
Manager 5.3 software. For categorical variables, groups
were compared using logistic regression analysis. Poor
sleep/severe fatigue was inserted as the dependent
variable, study center was included as a covariate, and the
results are given as odds ratios (ORs).
As the main analyses were performed on an
intention-to-treat approach where missing values were
imputed, a sensitivity analysis based on available data was
also conducted. Statistical analyses were performed using
SPSS version 21. P < .05 was considered statistically
significant.
Role of the Funding Source
The funder played no role in the design, conduct, or
reporting of this study.
Results
Participants
A total of 100 patients with axSpA were included between
August 2015 and September 2016. Fifty participants were
allocated to the exercise group and 50 participants to the
control group. The last 3-month assessments were
performed in December 2016. Flow of participants
throughout the trial is shown in Figure 1. Personal
characteristics and disease-related variables at baseline are
shown in Table 1.
Adherence and Safety
A total of 38 patients (76%) in the exercise group followed
≥80% of the prescribed exercise protocol (completed ≥29
of 36 sessions). Four (8%) patients quit the exercise
program right after the starting date (for reasons, see
Fig. 1). In general, based on reports from the physical
therapist, all the participants met 90% to 95% of HR max
during the intervals. However, 1 patient experienced chest
pain and nausea during the exercises and completed the
intervention at moderate intensity (64%–76% of HR max16)
after advice from a cardiologist. No acute adverse events
were reported during the exercise session, but 2 patients
reported persistent pain during exercise. In the control
group, 5 patients (10%) reported that they had performed
cardiorespiratory or strength exercises ≥2 times a week
during the 3-month intervention period.
At the 12-month follow-up, 43 participants in the exercise
group reported their exercise habits and, at this time
point, 17 of 43 (40%) reported to regularly perform
strength and cardiorespiratory exercises.
Effect of the Exercise Program at 3-Month
Follow-up
A significant beneficial effect of the intervention was seen
on fatigue, vitality, and perceived general health and
mood at the 3-month follow-up (Tab. 2). Furthermore,
compared with the control group, the exercise group
reduced the rate of having severe fatigue (OR = 0.41 [95%
CI = 0.18–0.91], P = .03) and poor sleep quality
(OR = 0.34 [95% CI = 0.13–0.92], P = .03) at the 3-month
follow-up. There was no effect of the intervention on
sleep quality analyzed as a continuous variable. As shown
in the forest-plot in Figure 2, the effect sizes were medium
for fatigue, vitality, and perceived general health, whereas
it was small for mood and sleep quality.
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Figure 1.
Flow of study participants.
Long-Term Effect of the Exercise Program
As expected, differences between the groups in fatigue,
vitality, mood, sleep quality or perceived general health
were not sustained at 12-month follow-up (Tab. 2). The
medium to small effect sizes on the outcome measures
seen at the 3-month follow-up were no longer present at
the 12-month follow-up (Fig. 2). Furthermore, the number
of patients reporting to have “severe fatigue” (OR = 0.32
[95% CI = 0.39–1.48], P = .67) or “poor sleep quality”
(OR = 1.14 [95% CI = 0.46–2.83], P = .78) was similar in
the groups at the 12-month follow-up.
The sensitivity analysis provided similar findings as the
main analysis at the 3- and 12-month follow-up (data not
shown).
Discussion
This secondary analysis of the ESpA study showed that a
3-month high-intensity cardiorespiratory and strength
exercise program had a beneficial effect on fatigue,
vitality, and mood in patients with axSpA at the end of the
intervention. Furthermore, participants in the exercise
group had a lower OR for having poor sleep quality and
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Table 1.
Baseline Descriptive of All Participants, Exercise Group, and Control Groupa
All Participants, n = 100 Exercise Group, n = 50 Control Group, n = 50
Age, y, mean (min-max) 46.2 (23–69) 45.1 (23–68) 47.2 (24–69)
Sex, male, n (%) 47 (47%) 25 (50%) 22 (44%)
≥13 years education 58 (58%) 29 (58%) 29 (58%)
Married/cohabitant 76 (76%) 39 (78%) 37 (74%)
In work, n (%) 81 (81%) 42 (78%) 39 (78%)
Current smoking, n (%) 12 (12%) 5 (7%) 7 (14%)
Medication
NSAIDs, n (%) 71 (71%) 38 (76%) 33 (66%)
TNF inhibitor, n (%) 44 (44%) 22 (44%) 20 (40%)
Blood pressure medication 13 (13%) 8 (16%) 5 (10%)
Disease characteristics
Radiographic axSpA 70 (70%) 38 (76%) 32 (64%)
Disease activity (ASDAS-CRP), mean (SD) 2.6 (0.7) 2.6 (0.8) 2.7 (0.6)
Disease activity (BASDAI), mean (SD) 5.1 (1.6) 4.9 (1.6) 5.3 (1.5)
CRP, median (min-max) 2 (2–28) 2 (2–28) 2 (2–13)
ESR (mm/h), median (min-max) 8 (1–67) 8 (2–67) 8 (1–28)
Physical function (BASFI), median (min-max) 3.2 (0.2–9.1) 2.6 (0.2–6.7) 3.0 (0.4–9.1)
Spinal flexibility (BASMI), mean (SD) 2.8 (1.3) 2.9 (1.3) 2.6 (1.3)
Fatigue measures
Fatigueb (0–7, 7 = worst), mean (SD) 4.6 (1.3) 4.5 (1.2) 4.8 (1.3)
Severe fatigue (≥5), n (%) 57 (57%) 24 (48%) 33 (66%)
Vitalityc (0,100, 100 = best) 56.1 (15.7) 59.6 (12.8) 53.6 (17.9)
Moodd (0–36, 0 = best), mean (SD) 16.6 (5.7) 16.3 (6.3) 16.9 (5.1)
Sleep qualitye (0–21, 21 = worst), mean (SD) 9.1 (3.8) 9.2 (4.0) 9.1 (3.6)
Poor sleep (>5) 83 (83%) 42 (84%) 41 (83%)
Perceived general healthf (0–100, 100 = best) 54.6 (17.0) 56.0 (14.0) 53.2 (19.6)
aASDAS = Ankylosing Spondylitis Disease Activity Score (higher score = worse); BASDAI = Bath Ankylosing Spondylitis Disease Activity Index; BASFI = Bath
Ankylosing Spondylitis Functional Index; BASMI = Bath Ankylosing Spondylitis Metrology Index (All BAS instruments, 0–10, 10 = worst); CRP = C-reactive
protein; ESR = Erythrocyte sedimentation rate; NSAIDs = non-steroidal anti-inflammatory drugs; TNF = tumor necrosis factor.
bFatigue severity scale.
cRAND 36-item Short form Health Survey.
dGeneral Health Questionnaire.
ePittsburgh Sleep Quality Index.
fEuroQol (0–100) VAS scale.
severe fatigue than participants in the control group at the
3-month follow-up. There was no long-term effect of the
exercise program. However, a long-term effect of exercise
is not expected if the exercise is not maintained.16 The
short-time beneficial effects showed in this study are
important, as fatigue and sleep problems are 2 of the most
frequently cited health aspects in which patients with
axSpA would like to see an improvement.2,3 Indeed, it has
been reported that up to 60% of patients with axSpA are
affected by fatigue, and the prevalence of depression and
anxiety is also high.36 AxSpA usually occurs in young
adults, and therefore the negative effects of the disease on
fatigue, mood, and vitality may impact patients’ social and
working life through a considerable time span.36
To the best of our knowledge, the EspA study is the first
large scale study investigating the effects of high intensity
exercise in patients with axSpA. Previous exercise trials in
patients with axSpA have mainly focused on flexibility
exercises,37,38 and fatigue, sleep, and mood have seldom
been used as outcome measures. Nevertheless, our
findings are in line with the general perception that
physical activity has a positive effect on sleep, mood,
fatigue, vitality, and perceived health.16,17,39 Further, our







niversity Library of Trom
sø user on 12 February 2021
Exercise in Spondyloarthritis
Table 2.
The Effect of Exercise on Fatigue, Vitality, Emotional Distress, Sleep Quality, and General Health at 3- and 12-Month
Follow-Up
Exercise Group (n = 50) Control Group (n = 50) Effect 3 Mo Effect 12 Mo
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aValues are shown as mean with SD, or differences with confidence intervals. Fatigue: the fatigue severity scale.
bVitality: Rand 36-item short form Health Survey.
cMood: the general health questionnaire.
dSleep quality with the Pittsburgh Sleep Quality Index.
ePerceived general health with the EuroQol (0–100) VAS scale.
fEstimated mean group difference, analyzed with ANCOVA with adjustments for baseline values and study center.
result is consistent with a recent meta-analysis reporting a
small beneficial effect of cardiorespiratory and strength
exercises on fatigue in patients with inflammatory
rheumatic diseases.19 The effect on fatigue was larger in
the present study than in the meta-analysis, probably
explained by higher exercise intensity.
In addition, our findings are also consistent with a
randomized controlled trial reporting a significant
beneficial effect of exercise on sleep in patients with
rheumatoid arthritis.40 Although we found a small but
non-significant effect on sleep measured with PSQI as a
continuous variable, the improvement of a mean 1.0 point
in PSQI in the exercise group was comparable with the
result reported by Durcan et al.40 Hence, the difference in
results between Durcan et al40 and the present study may
be due to differences in baseline values and statistical
analyses.
The mechanisms behind the observed positive effects on
fatigue, sleep, mood, and perceived health may be
explained by the beneficial effect of the intervention on
inflammation, physical fitness, and pain,20 variables that
are all closely related to our outcomes of interest. Firstly,
the effect may be explained by the anti-inflammatory
effect of exercise41 as inflammation is thought to play a
role in the multifactorial development of disease
symptoms such as fatigue. Secondly, the improvement in
physical fitness increases the patients’ available reserve
capacity and may thereby have beneficial effects on
fatigue and vitality. Thirdly, the improvement in pain may
have a positive impact on sleep as poor sleep in axSpA
often is caused by pain in the second part of the night.1 In
addition, the observed beneficial effects might have been
caused by group interaction as the exercises were
performed in a group setting for some of the participants.
Hence, exercise has the potential to improve fatigue,
sleep, and mood through various pathways, and the
observed effect in the current study can probably be
explained by an interaction of different mechanisms.
Even if small to moderate standardized effect sizes were
found after intervention in the current study, the effect
sizes were generally smaller than the reported Minimal
Clinical Important Difference (MCID) values. For instance,
the MCID for FSS is reported to be an effect size of 0.74 in
patients with rheumatoid arthritis to move to a different
fatigue category42 compared with 0.58 seen in our study,
and for the SF-36 vitality score the MCID is −10.7 (95%
CI = 5.9–15.5)42 compared with 5 points in our study.
As expected, no long-term effects of the exercise program
were seen on any of the secondary outcomes, as effects of
exercising are dependent on regular participation.
Exercise-induced adaptations are reversed over time
without adherence to the exercise program, and it is
difficult for people to adhere to physical activity at a high
intensity level.16 In the present trial, no follow-up or
monitoring was provided after the end of the 3-month
program. At the 12-month follow-up, less than one-half of
the participants in the exercise group reported regularly
performing cardiorespiratory and strength exercises.
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Figure 2.
Forest plot of the effect of exercise on fatigue, vitality, mood, sleep quality, and perceived general health at 3- and 12-month follow-up. Data
are shown as standardized mean difference (SMD, effect sizes) with 95% CI. SMDs between 0.2 and 0.4 are considered a small effect size,
from 0.5 to 0.7 a medium effect size, and ≥0.8 a large effect size.
Hence, we therefore did not expect effect of the exercise
program on fatigue, sleep, or mood 9 months after the
end of the program.
Fatigue and lack of energy is frequently reported as a
barrier for being physically active,43,44 and it is easy to
imagine that the feeling of being exhausted particularly is
a barrier for participation in high-intensity exercise. In the
same way, energy conservation has traditionally been
recommended by health personnel in the management of
fatigue and chronic pain.45 Although there is a general
perception that graded aerobic exercise has a beneficial
effect on chronic fatigue,6 there is a gap between graded
aerobic exercise and high-intensity exercise like the
intervention in the present study. The finding of a positive
effect on fatigue and vitality after high-intensity exercises
is interesting and should be taken into account when
considering energy conservation in the management of
fatigue. In addition, since pharmacological treatment has
failed to show an effect on fatigue,10 it can be argued that
high-intensity exercise is an important therapeutic tool in
the management of fatigue in patients with axSpA.
Strengths of the current randomized controlled trial
include the study design and the pragmatic approach. The
intervention was delivered by a local physical therapist at
4 different centers, which increases the generalizability of
the results. Due to the demanding exercise program, we
may have recruited motivated patients, which can have
biased the results. Nevertheless, the majority of the
patients were recruited from outpatient clinics, and almost
one-half of them were treated with tumor necrosis factor
inhibitors, thus strengthening the generalizability of the
results. Further, the exercise program followed generic
exercise guidelines, the adherence to the exercise protocol
was high, and losses to follow-up were very low.
The main limitation with the present study is the lack of
blinding of participants, which is not possible when
comparing exercise with no intervention. Further, a
limitation is that all the outcomes are secondary outcomes
of the randomized controlled trial, and therefore we
cannot rule out a problem with multiple testing. However,
the results were consistent, showing a beneficial effect of
the exercise program on all secondary outcomes, which
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limits the risk of statistical chance. Lack of blinding of
participants represents a risk of bias46 as all the outcome
measures were self-reported. Despite this, beneficial
effects of the intervention on objective outcomes such as
physical fitness and C-reactive protein20 strengthen the
validity of the results. Adverse events during the
intervention period were only registered in the exercise
group, and the groups therefore cannot be compared
regarding this issue. Finally, 3 participants in the exercise
group discontinued the intervention because they were
not satisfied with the exercises, hence indicating that
high-intensity exercise is not feasible for all individuals
with axSpA.
In conclusion, this is the first large-scale study, to our
knowledge, to demonstrate that a high-intensity
cardiorespiratory and strength exercise program has a
short-term beneficial effect on fatigue, vitality, sleep, and
mood in patients with axSpA, but, as expected, long-term
effects were not seen. High-intensity exercises should
therefore be recommended as a part of the management,
and strategies for long-term exercise adherence should be
developed.
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